Sandoz's Zarxio: Interactive Timeline Of Regulatory, Legal And Commercial Milestones
This article was originally published in The Pink Sheet Daily
Executive Summary
Experience a visual overview of key events surrounding the first US biosimilar approval under the 351(k) pathway, including its Sept. 3 launch.